Nondispersive infrared spectrometry (NDIRS) was used to detect Helicobacter pylori infection with the 13 C-urea breath test. The results were compared with those of standard isotope ratio mass spectrometry (IRMS). Both methods accurately distinguished between H. pylori -positive and H. pylori -negative individuals. The results demonstrate that NDIRS technology is accurate and therefore of equal value to standard IRMS for detection of H. pylori infection. It can be recommended for routine clinical application. As NDIRS technology is much cheaper than current IRMS machines, we consider the new method extremely useful for clinical applications.
Helicobacter pylori is a gram-negative bacterium that causes tests in clinical routine [10] . Initial studies suggested that NDIRS appeared to be of equal value to the conventional IRMS infection of the gastric mucosa in humans. A significant amount of evidence has been accumulated in the past decade that shows for the analysis of 13 CO 2 in breath samples [11] . Therefore, the aim of the present study was to measure 13 CO 2 concentrathat H. pylori causes chronic superficial gastritis [1] and that there is a strong association between H. pylori infection and tions with a new, commercially available NDIRS analyzer and to compare the results to those of standard IRMS analysis in peptic ulcer disease [2] .
A fundamental principle for specific antimicrobial therapy a series of patients with defined H. pylori status. is accurate diagnosis. There are several validated methods for diagnosis of H. pylori infection, and they can be divided into Methods invasive and noninvasive tests. The invasive tests include enForty patients who were referred for routine 13 CO 2 urea doscopy, with biopsy specimens examined histologically for breath tests after an overnight fast were investigated. For the H. pylori, microbiological culture, and direct detection of urepurpose of this study, the standard IRMS breath test was conase activity in the gastric tissue. Noninvasive tests include sidered diagnostic of H. pylori status [7 -9, 11], and no addiserology and breath tests.
13
C-labeled urea is used to detect the tional endoscopic, histologic, or cultural studies were done. presence of H. pylori infection by a breath test [3] . The test is Breath samples were collected in parallel in aluminized breath highly sensitive and specific, and it is considered by many to bags and into 15-mL Vacutainers (Becton Dickinson, Sparks, be the ''gold standard'' of noninvasive testing [4, 5] . The 13 C-MD) during fasting and 30 minutes after ingestion of 100 mg urea breath test has been applied to thousands of patients and of 13 C-urea dissolved in 30 mL of water and diluted in healthy volunteers, and excellent epidemiological data have 250 mL of orange juice, which was used to delay gastric empbeen obtained regarding children and adults as well as patients tying. with peptic ulcer disease [6 -9].
Vacutainers were analyzed by IRMS (VG Isotech, MidUp to now, stable isotope analysis of breath samples of urea dlewich, Cheshire, UK). NDIRS analysis was done in duplicate breath tests was carried out by very sensitive -but equally with the bags directly connected to the spectrometer, which expensive -isotope ratio mass spectrometry (IRMS). The high allows on-line analysis of breath samples (IRIS Analysator, costs of these analyzers and the need for skilled personnel have Wagner Analysen Technik, Worpswede, Germany were assessed according to Bland and Altman [13] .
in figure 1 . The fact that the results analyzed by both methods lie close along the line of identity is not surprising, as both methods quantify the same samples. More important is the clinically relevant fact that both methods accurately distinguish between H. pylori -positive and H. pylori -negative subjects. Neither method produced false-negative or false-positive results as judged by a cutoff value of 5‰; the subject with an arbitrary DOB value of 5.1‰ as analyzed by IRMS showed a clearly positive value of 6.7‰ by NDIRS ( figure 1 ). To more precisely compare the new NDIRS with the established IRMS method, the sensitivity of which is higher than needed for clinical purposes, the measured differences of individual results were plotted against the mean of both results (figure 2). The middle line (00.23‰) depicts the mean of all differences, whereas the upper and lower lines indicate {2 standard deviations of the differences. If the differences follow can be used as measurement methods to analyze 13 CO 2 breath samples. We refer to these differences as the ''limits of agreement.'' For the results the mean difference is 00.23 DOB‰ difference to increase with higher values of the average DOB and the standard deviation is 1.11 DOB‰.
value (figure 2), this potential bias does not interfere in the Thus, both methods provide results that are largely acceptmore important lower region of values (i.e., DOB 5‰), where able for clinical purposes. Although there is a tendency of the the measurements have to discriminate between baseline and elevated values, thus discriminating between H. pyloripositive and H. pylori -negative individuals. Another important parameter of the quality of a method is the repeatability of measurements. Again, we expect 95% of the differences to be less than 2 standard deviations, which is the definition of the coefficient of repeatability according to the British Standards Institution [14] . Figure 3 shows the differences between two measurements of the same breath sample analyzed by NDIRS, plotted against the mean of both values. There does not appear to be any relation between the difference and the absolute value of the DOB measurements. The mean was close to zero (00.14‰) and the standard deviation was 0.82‰, resulting in a coefficient of repeatability of 1.64‰ for NDIRS.
Discussion
The urea breath test is probably at present the most popular breath test used in clinical medicine. It is most useful for epidemiological studies of the prevalence of H. pylori and for evaluating the therapeutic success of antimicrobial treatment of H. pylori -infected patients with ulcers. However, the high C-labeled substrates. However, this is not a real disadvantage, as all presently available substrates used in clinical tests are based on 13 C compounds. We therefore consider NDIRS extremely useful for clinical practice.
